Northwestern University Feinberg School of Medicine
Skip to main content

Living With Cancer: A Delicate Imbalance - Video

A Vlog Post by Chuck Maniscalco  | Dec. 6, 2017

Today’s blog is actually a vlog—and a bit of a departure from previous ones.  The attached video is an excerpt of a speech about coping with cancer.  It is focused on the insights I had, along with the life lessons that emerged.  My care team at the Lurie Cancer Center has kept me alive for the last year and a half.  Staying true to these life lessons has allowed me to not just be alive, but back in my life.  If you have 14 minutes to spare, take a look—it might just help you, too.

 

About Chuck Maniscalco

Chuck ManiscalcoDiagnosed with Stage IV lung cancer in October 2016, Chuck is benefitting from the advanced, individualized and research-based treatment options offered at the Lung OncoSET, part of the Lurie Cancer Center.

Chuck is currently retired, after a long career in business, including President of Gatorade, CEO of Quaker, Tropicana and Gatorade, and CEO of Seventh Generation. He is an avid runner, guitar player, and takes daily joy in completing the NY Times Crossword Puzzles.

Email Chuck Maniscalco

About Lung OncoSET

The Lung OncoSET is an extension of the Lurie Cancer Center's breakthrough OncoSET Program. OncoSET (Sequence, Evaluate, Treat) is based on the premise that each individual and every person's cancer is unique. It harnesses the power of precision medicine to identify tailored therapies for patients based on the abnormal genes specific to their tumor.

In 2014, the Lurie Cancer Center became the first academic cancer center in Chicago and one of only a handful in the nation to provide this kind of personalized medicine to patients with tumors — especially those tumors that are resistant to traditional cancer therapies. Learn more about Lung OncoSET and support more effective treatments for patients with lung cancer.

Support Lung OncoSET

Recent Posts

A Delicate Imbalance - Video (12/6/2017)

The Importance of Research (9/21/2017)

Is Immunotherapy a Panacea? (6/22/2017)

Cancer: Literally a Matter of Life and Death, and More (5/11/2017)

Cancer: Why Do We Need Precision Medicine? (5/1/2017)

Thriving with Cancer (3/28/2017)
About Lung OncoSET The Lung OncoSET is an extension of the Lurie Cancer Center's breakthrough OncoSET Program. OncoSET (Sequence, Evaluate, Treat) is based on the premise that each individual and every person's cancer is unique. It harnesses the power of precision medicine to identify tailored therapies for patients based on the abnormal genes specific to their tumor. In 2014, the Lurie Cancer Center became the first academic cancer center in Chicago and one of only a handful in the nation to provide this kind of personalized medicine to patients with tumors — especially those tumors that are resistant to traditional cancer therapies. Learn more about Lung OncoSET and support more effective treatments for patients with lung cancer. Support Lung OncoSET Recent Posts The Importance of Research (9/21/2017) Is Immunotherapy a Panacea? (6/22/2017) Cancer: Literally a Matter of Life and Death, and More (5/11/2017) Cancer: Why Do We Need Precision Medicine? (5/1/2017) Thriving with Cancer (3/28/2017)/about/news/_shared/maniscalco-footerFSM-LCCmaniscalco-footer
Back to top